News from Wisconsin Alzheimer's Institute
UW shows strong presence at AAIC 2021
The world’s largest and most prestigious Alzheimer’s disease conference is underway this week, and UW Alzheimer’s disease researchers are attending in high numbers, leading several important discussions.
Dr. Mora Pinzon discusses obstacles to care for Latinx people with dementia
WAI scientist Maria Mora Pinzon, PhD, recently discussed the health disparity on Chicago, Ill media outlets.
Groundbreaking AHEAD study recruiting participants ages 55 and older
WAI Director Cynthia Carlsson, MD, MS, leads the AHEAD study.
Dr. Mora Pinzon contributes to Spanish language BrainGuide
Thank you NBC15 for featuring the guide and Dr. Mora Pinzon's contributions.
Dr. Walaszek interviewed on WPR about Alzheimer’s drug aducanumab
Art Walaszek, MD, public health leader for WAI, was a guest on WPR to discuss the Alzheimer's disease drug aducanumab and its approval by the FDA.
FDA approves aducanumab for Alzheimer’s disease treatment
On June 7, the U.S. Food and Drug Administration (FDA) approved the drug aducanumab for the treatment of Alzheimer’s disease. Read a breakdown on what this means for people living with Alzheimer's disease and family caregivers.
WAI Regional Milwaukee office and Dr. Norris featured in MKE Lifestyle magazine
Thank you MKE Lifestyle for a feature article about WAI Regional Milwaukee Office and their work addressing Alzheimer's disease and dementia in the Milwaukee community.
Dr. Mora Pinzon presents at US Against Alzheimer’s event
Watch a recording from COVID-19 and Brain Health: Advancing Equity for Caregivers and Community event
Welcome WAI Administrator Sarah Klein
Wisconsin Alzheimer's Institute (WAI) is excited to welcome Sarah Klein in her new role as WAI administrator.
Gina Green Harris featured on Super Aging podcast
Harris joined the program to discuss health disparities and dementia and strategies for change.
- Read more news from WAI